MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis
- 01 November 2025
- 23 hours ago
Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin
- 01 November 2025
- 23 hours ago
CDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV Study
- 24 September 2025
- 1 month ago
Biocon Gets CDSCO Panel Nod to Import Aflibercept Injection for Eye Disorders, Phase IV Trial Mandated
- 21 September 2025
- 1 month ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.





